<DOC>
	<DOCNO>NCT02579265</DOCNO>
	<brief_summary>To show superiority safety Smoflipid Intralipid® measure number study patient treatment group conjugate bilirubin exceed 2 mg/dL first 28 day study treatment , confirm second sample collect 7 day first sample .</brief_summary>
	<brief_title>Phase 3 Study Compare Safety Efficacy Smoflipid 20 % Intralipid 20 % Hospitalized Neonates Infants</brief_title>
	<detailed_description />
	<mesh_term>Soybean oil , phospholipid emulsion</mesh_term>
	<mesh_term>Parenteral Nutrition Solutions</mesh_term>
	<criteria>Neonates infant , expect require parenteral nutrition ( PN ) 28 day Postmenstrual age ≥ 24 week Birth weight ≥ 750g Gastroschisis , duodenal , jejunal ileal atresia , volvulus , spontaneous intestinal perforation necrotizing enterocolitis ( Bell 's stage 2B high ) At least 80 % nutritional need baseline receive PN Signed date informed consent obtain least one parent legal guardian Conjugated bilirubin &gt; 0.6 mg/dL Any known pre , intra posthepatic complication increase conjugate bilirubin level &gt; 0.6 , mg/dL study participation Suspected liver disease liver damage base either aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) , gammaglutamyl transferase ( GGT ) exceed 2.5x upper limit normal range Active bloodstream infection demonstrate positive blood culture screen Cystic fibrosis Meconium ileus Serum triglyceride level &gt; 250 mg/dL Cyanotic congenital heart defect Severe renal failure serum creatinine &gt; 2.0 mg/dL History shock require vasopressor Anasarca Extracorporeal Membrane Oxygenation ( ECMO ) Known inborn error metabolism Known congenital viral infection Unlikely survive longer 28 day Known hypersensitivity fish , egg , soya peanut protein active substance excipients</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Parenteral nutrition</keyword>
	<keyword>Neonates</keyword>
	<keyword>Infants</keyword>
	<keyword>Lipid emulsion</keyword>
	<keyword>Intravenous</keyword>
</DOC>